Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon

Vaccine Refusal Clinical Trial

Official title:

Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents With Children Aged 9-14yrs Within Rural Communities in North West Region, Cameroon

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05325138
• Other study ID #: 100035
• Status: Recruiting
• Start date: March 14, 2022
• Est. completion date: January 31, 2023

Study information

• Verified date: April 2022
• Source: McMaster University
• Contact: Lorraine M Elit, MD MSc
• Phone: 9055182921
• Email: elitl[@]mcmaster.ca
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. To do this, we will conduct in-depth qualitative interviews with purposively sampled parents of girls aged 9 to 14 years, some of whom received HPV vaccine and some of whom did not. Interviews will continue until thematic saturation is reached (We anticipate a total 40 interviews). Data analysis will be done concurrently with interviews using thematic analysis.

Description:

The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. Snowball sampling technique will be used. Parents of girls aged 9-14years will be included if the daughters have or have not received the HPV vaccine. Exclusion criteria include parents who are health care workers in any health institution, unwilling to provide consent, or inability to converse in English or pidgeon English. In-depth one-on-one interviews will take place using an interview guide. Interviews will be in English or pidgeon English. They will be taped and transcribed. Data will be entered into ATLAS Ti. Data analysis will be done concurrently with interviews using thematic analysis.Interviews will continue until theme saturation is reached (We anticipate a total 40 interviews).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 45
• Est. completion date: January 31, 2023
• Est. primary completion date: January 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Parents of girls aged 9-14 years old living in Mbingo, Njinikom or Fundong health areas of northwestern Cameroon.

Exclusion Criteria:

• Parents who are health care workers or working in any health institution.

• Not willing to provide informed consent

• Not able to converse in English or pidgeon English

Related Conditions & MeSH terms

• Vaccine Refusal

Intervention

Other:
• Interview
Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination

Locations

Country	Name	City	State
Cameroon	Mbingo Hosptial	Bamenda	North West

Sponsors (2)

Lead Sponsor	Collaborator
McMaster University	Merck Canada Inc.

Country where clinical trial is conducted

Cameroon, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HPV vaccine knowledge, attitudes and beliefs	Interviews of parents of girls (ages 9-14 years old)	6months